InvestorsHub Logo
Followers 79
Posts 24490
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 04/15/2024 7:47:51 AM

Monday, April 15, 2024 7:47:51 AM

Post# of 27395
SNGX - .3861 Pre-market .564/.57

FDA Grants Soligenix Orphan Drug Designation To Active Ingredient In MarVax For Prevention And Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.